Sharon Kapambwe: The Global Platform for Access to Childhood Cancer Medicines
Sharon Kapambwe, Technical Officer of Cancer Control at the World Health Organization, shared a post on LinkedIn:
“Every year, an estimated 400 000 children worldwide develop cancer. The majority of these children, living in resource-limited settings, are unable to consistently obtain or afford cancer medicines.
It is estimated that 70% of the children from these settings die from cancer due to factors such as lack of appropriate treatment, treatment disruptions or low-quality medicines.
The Global Platform for Access to Childhood Cancer Medicines (Global Platform) aims to provide an uninterrupted supply of quality-assured cancer medicines to low- and middle-income countries (LMICs). It is a first initiative of its kind.
Countries in the pilot phase will receive an uninterrupted supply of quality-assured childhood cancer medicines at no cost. In low- and middle-income countries (LMICs) countries, childhood cancer survival rates are often below 30%, significantly lower than those in high-income countries.
The initiative is poised to become the largest, with the goal of reaching 50 nations in the next 5 to 7 years. It aims to eventually provide medicines for the treatment of approximately 120 000 children with cancer in LMICs, significantly reducing mortality rates.
Congratulations to Ecuador, Jordan, Mongolia, Nepal, Uzbekistan and Zambia the pilot countries!!
Six additional countries have been formally invited to join the platform.”
Proceed to the video attached to the post.
More posts featuring Sharon Kapambwe.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023